FDA Adverse Event Injury Summary report: N

BELLAFILL DERMAL FILLER

MDR report key: 24460519 · Received February 26, 2026

Report

Report Number
3003707320-2026-00002
Event Type
Injury
Date Received
February 26, 2026
Date of Event
January 26, 2026
Report Date
February 26, 2026
Manufacturer
TIGER AESTHETICS MEDICAL LLC
Product Code
LMH
PMA / PMN Number
P020012
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ON (B)(6) 2026, INJECTOR REPORTED MEDICAL INTERVENTION FOR A PATIENT WITH NODULES THAT APPEARED RECENTLY. PATIENT HAD BEEN INJECTED IN NASOBIAL FOLDS ~7 YEARS PRIOR. IT IS UNKNOWN AT THIS TIME IF MEDICAL INTERVENTION IS REQUIRED TO RESOLVE THE PATIENT'S ISSUE. NO FURTHER INFORMATION HAS BEEN PROVIDED AT THIS TIME. B3: DATE OF EVENT - 01/26/2026: DATE DOCTOR REPORTED MEDICAL INTERVENTION. B7: PATIENT HAD HYALURONIC ACID FILLERS IN THE SAME AREAS. PRODUCT BRAND IS UNKNOWN. D6A: IMPLANT DATE - BLANK. DATE OF IMPLANT IS UNKNOWN. WAS ~7 YEARS AGO. G3: DATE RECEIVED BY MANUFACTURER: 01/26/2026, DATE DOCTOR REPORTED MEDICAL INTERVENTION. D9: DEVICE NOT AVAILABLE FOR EVALUATION. BELLAFILL SYRINGES ARE SINGLE USE DEVICES THAT ARE TYPICALLY DISCARDED AFTER USE. PER BELLAFILL IFU: "THE SYRINGE AND ANY UNUSED MATERIAL SHOULD BE DISCARDED AFTER A SINGLE TREATMENT VISIT."

Description of Event or Problem · 0

ON (B)(6) 2026, INJECTOR REPORTED MEDICAL INTERVENTION FOR A PATIENT WITH NODULES THAT APPEARED RECENTLY. PATIENT HAD BEEN INJECTED IN NASOBIAL FOLDS ~7 YEARS PRIOR. IT IS UNKNOWN AT THIS TIME IF MEDICAL INTERVENTION IS REQUIRED TO RESOLVE THE PATIENT'S ISSUE. NO FURTHER INFORMATION HAS BEEN PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
257115 BELLAFILL DERMAL FILLER BELLAFILL DERMAL FILLER LMH TIGER AESTHETICS MEDICAL LLC GBF0508 F171062

Patients

Seq Age Sex Outcome Treatment
1 68 YR Unknown Required Intervention HYALURONIC ACID FILLER.